Biohaven Ltd [BHVN] stock is trading at $39.33, down -3.39%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The BHVN shares have gain 9.71% over the last week, with a monthly amount glided 8.47%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Biohaven Ltd [NYSE: BHVN] stock has seen the most recent analyst activity on September 16, 2024, when Jefferies initiated its Buy rating and assigned the stock a price target of $57. Previously, Bernstein started tracking the stock with Outperform rating on September 04, 2024, and set its price target to $55. On July 24, 2024, Morgan Stanley initiated with a Overweight rating and assigned a price target of $58 on the stock. RBC Capital Mkts started tracking the stock assigning a Outperform rating and suggested a price target of $62 on February 16, 2024. UBS initiated its recommendation with a Buy and recommended $59 as its price target on February 06, 2024. H.C. Wainwright started tracking with a Buy rating for this stock on December 22, 2023, and assigned it a price target of $50. In a note dated December 08, 2023, Robert W. Baird initiated an Outperform rating and provided a target price of $58 on this stock.
Biohaven Ltd [BHVN] stock has fluctuated between $26.80 and $62.21 over the past year. Currently, Wall Street analysts expect the stock to reach $59.5 within the next 12 months. Biohaven Ltd [NYSE: BHVN] shares were valued at $39.33 at the most recent close of the market. An investor can expect a potential return of 51.28% based on the average BHVN price forecast.
Analyzing the BHVN fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -1.58, Equity is -2.25 and Total Capital is -2.37. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.09.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 38.61 points at the first support level, and at 37.88 for the second support level. However, for the 1st resistance point, the stock is sitting at 40.45, and for the 2nd resistance point, it is at 41.56.
Ratios To Look Out For
For context, Biohaven Ltd’s Current Ratio is 2.89. As well, the Quick Ratio is 2.89, while the Cash Ratio is 0.55.
Transactions by insiders
Recent insider trading involved CHILDS JOHN W, Director, that happened on Dec 30 ’24 when 29000.0 shares were purchased. Director, CHILDS JOHN W completed a deal on Oct 02 ’24 to buy 21052.0 shares. Meanwhile, Chief Executive Officer Coric Vlad bought 21052.0 shares on Oct 02 ’24.
